MedTrace Logo

Comparison of Two Monitors That Measure Neuromuscular Function During Surgeries

NCT03987607 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2020-01-02

No results posted yet for this study

Summary

Anesthesiologists are often required to give certain drugs, called muscle relaxants to the patients for surgery. These drugs make the people weak for the procedure to make the work of the surgeon easier and prevent unexpected movements. The effect of these drugs must be terminated by the end of the procedures to ensure that the patients can breathe normally. Over the years several monitors have been developed to monitor the effect of these drugs. The monitors use different principles to measure muscle function. Some monitors are integrated into anesthesia machines while others are battery-operated, portable devices. The aim of the present study is two compare monitors using different technologies. Both monitors stimulate a peripheral nerve at the wrist that makes the thumb twitch. The older device (TOF-Watch SX) measures the acceleration of thumb movement, the new device (TetraGraph) measures the electrical activity of the muscle that moves the thumb. The two devices will be connected so that with one simulation both types of signals can be recorded and analyzed. The monitors will be used during the surgeries as described by the manufacturer. The study will not influence the surgical procedure or the anesthetic of the patients. The aim of the study is to collect data on how the two monitors correlate, since they measure neuromuscular function by different technologies (acceleromyography and electromyography).

Conditions

  • Neuromuscular Blockade

Interventions

DEVICE

neuromuscular blockade monitoring

Neuromuscular blockade monitoring via two different types of monitoring devices

Sponsors & Collaborators

  • Senzime AB

    collaborator INDUSTRY

  • Tamas Vegh, MD

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-06-17
Primary Completion
2019-12-18
Completion
2019-12-18
FDA Device
Yes

Countries

  • Hungary

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03987607 on ClinicalTrials.gov